Biomarkers and Therapeutical Targets for Prion Diseases

This book explores the intricate landscape of prion diseases, exploring the various methodologies for detecting human and animal prions, emphasizing both current techniques and those under development, as well as emerging techniques and methodologies for biomarker detection in prion diseases, paving...

Повний опис

Збережено в:
Бібліографічні деталі
Співавтор: SpringerLink (Online service)
Інші автори: Legname, Giuseppe (Редактор), Moda, Fabio (Редактор)
Формат: Електронний ресурс eКнига
Мова:Англійська
Опубліковано: Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
Редагування:1st ed. 2025.
Серія:Subcellular Biochemistry, 112
Предмети:
Онлайн доступ:https://doi.org/10.1007/978-3-031-97055-9
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Зміст:
  • Chapter 1. Advancements in Chronic Wasting Disease (CWD) Prion Detection: Moving Beyond The Gold Standards
  • Chapter 2. Diagnosis of Prion Diseases
  • Chapter 3. New Therapeutic Modalities in Prion Diseases
  • Chapter 4. Prion Disease Diagnostic Biomarker Utility In Pre-Symptomatic Disease
  • Chapter 5. Therapeutic Trajectories in Human Prion Diseases
  • Chapter 6. Prion and “Prion-Like” Detection: From Conventional Methods To Microfluidics Or Lab-On-Chip Platforms To Monitor Seeding And Spreading Of Misfolded Proteins
  • Chapter 7. Tracking Prions by RT-QuIC: an Update
  • Chapter 8. Reactive Microglia And Astrocytes As Therapeutic Targets In Prion Diseases
  • Chapter 9. Biological Fluid Biomarkers in Human Prion Diseases with a Note on Biosafety
  • Chapter 10. Human Genetic Evidence for New Targets in Prion Diseases –Opportunities and Challenges
  • Chapter 11. Advancing Prion Diagnostics: RT-QuIC Applications In Peripheral Tissues
  • Chapter 12. Detecting the Undetectable: Exploring The Diagnostic Potential Of Protein Misfolding Cyclic Amplification In Human Prion Diseases
  • Chapter 13. Seed Amplification Assays As Powerful Tools For Detecting Peripheral Biomarkers In Prion-Like Diseases.